A novel antisense long noncoding RNA within the IGF1Rgene locus is imprinted in hematopoietic malignancies

Nucleic Acids Research

Volumn 42, Issue 15, 2014, Pages 9588-9601

  Sun, Jingnan ^a,b   Li, Wei ^a   Sun, Yunpeng ^a   Yu, Dehai ^a,b   Wen, Xue ^a   Wang, Hong ^a,b   Cui, Jiuwei ^a   Wang, Guanjun ^a   Hoffman, Andrew R ^b   Hu, Ji Fan ^a,b  

^a JILIN UNIVERSITY   (China)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE LONG NONCODING RNA IRAIN; GENOMIC DNA; LONG UNTRANSLATED RNA; SHORT HAIRPIN RNA; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG; CHROMATIN; COMPLEMENTARY RNA; DNA;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; BIOASSAY; CANCER PATIENT; CHROMATIN CONFORMATION CAPTURE ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA SEQUENCE; DOWN REGULATION; ENHANCER REGION; EPIGENETICS; GENE EXPRESSION REGULATION; GENE INTERACTION; GENE LOCUS; GENE SILENCING; HEMATOLOGIC MALIGNANCY; HIGH RISK PATIENT; HISTONE METHYLATION; HUMAN; HUMAN CELL; IGF1R GENE; INTRACHROMOSOMAL ENHANCER; INTRACHROMOSOMAL INTERACTION; INTRON; LEUKEMIA CELL LINE; NUCLEIC ACID PROBE; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION ASSOCIATED TRAP ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION; ALLELE; CHEMISTRY; CHROMATIN; GENETICS; GENOME IMPRINTING; LEUKEMIA; LEUKOCYTE; METABOLISM; TUMOR CELL LINE;

ALLELES; CELL LINE, TUMOR; CHROMATIN; DNA; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC LOCI; GENOMIC IMPRINTING; HUMANS; LEUKEMIA; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTES; RECEPTOR, IGF TYPE 1; RNA, ANTISENSE; RNA, LONG NONCODING;

EID: 84925451545     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku549     Document Type: Article

References (75)

1. Seccareccia, E. and Brodt, P. (2012) The role of the insulin-like growth factor-I receptor in malignancy: an update. Growth Horm. IGF Res., 22, 193-199.
2. Pollak, M. (2012) The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nat. Rev. Cancer, 12, 159-169.
3. Ozkan, E.E. (2011) Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: a review. Mol. Cell. Endocrinol, 344, 1-24.
4. Capoluongo, E. (2011) Insulin-like growth factor system and sporadic malignant melanoma. Am. J. Pathol., 178, 26-31.
5. Gallagher, E.J. and LeRoith, D. (2010) The proliferating role of insulin and insulin-like growth factors in cancer. Trends Endocrinol. Metab., 21, 610-618.
6. Chapuis, N., Tamburini, J., Cornillet-Lefebvre, P., Gillot, L., Bardet, V., Willems, L., Park, S., Green, A.S., Ifrah, N., Dreyfus, F. et al. (2010) Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody. Haematologica, 95, 415-423.
7. Grandage, V.L., Gale, R.E., Linch, D.C. and Khwaja, A. (2005) PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappaB, Mapkinase and p53 pathways. Leukemia, 19, 586-594.
8. Xu, Q., Simpson, S.E., Scialla, T.J., Bagg, A. and Carroll, M. (2003) Survival of acute myeloid leukemia cells requires PI3 kinase activation. Blood, 102, 972-980.
9. Doepfner, K.T., Spertini, O. and Arcaro, A. (2007) Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway. Leukemia, 21, 1921-1930.
10. Ge, N.L. and Rudikoff, S. (2000) Insulin-like growth factor I is a dual effector of multiple myeloma cell growth. Blood, 96, 2856-2861.
11. Sprynski, A.C., Hose, D., Caillot, L., Reme, T., Shaughnessy, J.D. Jr, Barlogie, B., Seckinger, A., Moreaux, J., Hundemer, M., Jourdan, M. et al. (2009) The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor. Blood, 113, 4614-4626.
12. Sprynski, A.C., Hose, D., Kassambara, A., Vincent, L., Jourdan, M., Rossi, J.F., Goldschmidt, H. and Klein, B. (2010) Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation. Leukemia, 24, 1940-1950.
13. Abe, S., Funato, T., Takahashi, S., Yokoyama, H., Yamamoto, J., Tomiya, Y., Yamada-Fujiwara, M., Ishizawa, K., Kameoka, J., Kaku, M. et al. (2006) Increased expression of insulin-like growth factor i is associated with Ara-C resistance in leukemia. Tohoku J. Exp. Med., 209, 217-228.
14. Wahner Hendrickson, A.E., Haluska, P., Schneider, P.A., Loegering, D.A., Peterson, K.L., Attar, R., Smith, B.D., Erlichman, C., Gottardis, M., Karp, J.E. et al. (2009) Expression of insulin receptor isoform A and insulin-like growth factor-1 receptor in human acute myelogenous leukemia: effect of the dual-receptor inhibitor BMS-536924 in vitro. Cancer Res., 69, 7635-7643.
15. Medyouf, H., Gusscott, S., Wang, H., Tseng, J.C., Wai, C., Nemirovsky, O., Trumpp, A., Pflumio, F., Carboni, J., Gottardis, M. et al. (2011) High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling. J. Exp. Med., 208, 1809-1822.
16. Karamouzis, M.V. and Papavassiliou, A.G. (2012) Targeting insulin-like growth factor in breast cancer therapeutics. Crit. Rev. Oncol. Hematol., 84, 8-17.
17. Tognon, C.E. and Sorensen, P.H. (2012) Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy. Expert Opin. Ther. Targets, 16, 33-48.
18. Rowinsky, E.K., Schwartz, J.D., Zojwalla, N., Youssoufian, H., Fox, F., Pultar, P., Novosyadlyy, R., Cosaert, J. and Ludwig, D.L. (2011) Blockade of insulin-like growth factor type-1 receptor with cixutumumab (IMC-A12): a novel approach to treatment for multiple cancers. Curr. Drug Targets, 12, 2016-2033.
19. Buck, E. and Mulvihill, M. (2011) Small molecule inhibitors of the IGF-1R/IR axis for the treatment of cancer. Expert Opin. Investig. Drugs, 20, 605-621.
20. Heidegger, I., Pircher, A., Klocker, H. and Massoner, P. (2011) Targeting the insulin-like growth factor network in cancer therapy. Cancer Biol. Ther., 11, 701-707.
21. Moreau, P., Cavallo, F., Leleu, X., Hulin, C., Amiot, M., Descamps, G., Facon, T., Boccadoro, M., Mignard, D. and Harousseau, J.L. (2011) Phase I study of the anti insulin-like growth factor 1 receptor (IGF-1R) monoclonal antibody, AVE1642, as single agent and in combination with bortezomib in patients with relapsed multiple myeloma. Leukemia, 25, 872-874.
22. Zhang, H., Zeitz, M.J., Wang, H., Niu, B., Ge, S., Li, W., Cui, J., Wang, G., Qian, G., Higgins, M.J. et al. (2014) Long noncoding RNA-mediated intrachromosomal interactions promote imprinting at the Kcnq1 locus. J. Cell Biol., 204, 61-75.
23. Batista, P.J. and Chang, H.Y. (2013) Long noncoding RNAs: cellular address codes in development and disease. Cell, 152, 1298-1307.
24. Prasanth, K.V. and Spector, D.L. (2007) Eukaryotic regulatory RNAs: an answer to the 'genome complexity' conundrum. Genes Dev., 21, 11-42.
25. Magistri, M., Faghihi, M.A., St Laurent, G. III and Wahlestedt, C. (2012) Regulation of chromatin structure by long noncoding RNAs: focus on natural antisense transcripts. Trends Genet., 28, 389-396.
26. Shin, J.Y., Fitzpatrick, G.V. and Higgins, M.J. (2008) Two distinct mechanisms of silencing by the KvDMR1 imprinting control region. EMBO J., 27, 168-178.
27. Mercer, T.R. and Mattick, J.S. (2013) Structure and function of long noncoding RNAs in epigenetic regulation. Nat. Struct. Mol. Biol., 20, 300-307.
28. Lee, J.T. (2012) Epigenetic regulation by long noncoding RNAs. Science, 338, 1435-1439.
29. Mancini-DiNardo, D., Steele, S.J., Ingram, R.S. and Tilghman, S.M. (2003) A differentially methylated region within the gene Kcnq1 functions as an imprinted promoter and silencer. Hum. Mol. Genet., 12, 283-294.
30. Thakur, N., Tiwari, V.K., Thomassin, H., Pandey, R.R., Kanduri, M., Gondor, A., Grange, T., Ohlsson, R. and Kanduri, C. (2004) An antisense RNA regulates the bidirectional silencing property of the Kcnq1 imprinting control region. Mol. Cell. Biol., 24, 7855-7862.
31. Hu, J.F., Vu, T.H. and Hoffman, A.R. (1996) Promoter-specific modulation of insulin-like growth factor II genomic imprinting by inhibitors of DNA methylation. J. Biol. Chem., 271, 18253-18262.
32. Hu, J.F., Oruganti, H., Vu, T.H. and Hoffman, A.R. (1998) Tissue-specific imprinting of the mouse insulin-like growth factor II receptor gene correlates with differential allele-specific DNA methylation. Mol. Endocrinol., 12, 220-232.
33. Yao, X.M., Hu, J.F., Daniels, M., Li, T., Yang, Y.W., Li, Z.H., Vu, T.H. and Hoffman, A.R. (2004) Epigenetic regulation of the taxol resistance-associated gene TRAG-3 in human tumors. Cancer Genet. Cytogenet., 151, 1-13.
34. Li, T., Hu, J.F., Qiu, X., Ling, J., Chen, H., Wang, S., Hou, A., Vu, T.H. and Hoffman, A.R. (2008) CTCF regulates allelic expression of Igf2 by orchestrating a promoter-polycomb repressive complex-2 intrachromosomal loop. Mol. Cell. Biol., 28, 6473-6482.
35. Zhang, S., Zhong, B., Chen, M., Yang, G., Li, Y., Wang, H., Wang, G., Li, W., Cui, J., Hoffman, A.R. et al. (2014) Epigenetic reprogramming reverses the malignant epigenotype of the MMP/TIMP axis genes in tumor cells. Int. J. Cancer, 134, 1583-1594.
36. Chen, H.L., Li, T., Qiu, X.W., Wu, J., Ling, J.Q., Sun, Z.H., Wang, W., Chen, W., Hou, A., Vu, T.H. et al. (2006) Correction of aberrant imprinting of IGF2 in human tumors by nuclear transfer-induced epigenetic reprogramming. EMBO J., 25, 5329-5338.
37. Dekker, J., Rippe, K., Dekker, M. and Kleckner, N. (2002) Capturing chromosome conformation. Science, 295, 1306-1311.
38. Zhang, H., Jiao, W., Sun, L., Fan, J., Chen, M., Wang, H., Xu, X., Shen, A., Li, T., Niu, B. et al. (2013) Intrachromosomal looping is required for activation of endogenous pluripotency genes during reprogramming. Cell Stem Cell, 13, 30-35.
39. Zhang, H., Niu, B., Hu, J.F., Ge, S., Wang, H., Li, T., Ling, J., Steelman, B.N., Qian, G. and Hoffman, A.R. (2011) Interruption of intrachromosomal looping by CCCTC binding factor decoy proteins abrogatesgenomic imprinting of human insulin-like growth factorII. J. Cell Biol., 193, 475-487.
40. Kedinger, C., Gniazdowski, M., Mandel, J.L. Jr, Gissinger, F. and Chambon, P. (1970) Alpha-amanitin: a specific inhibitor of one of two DNA-pendent RNA polymerase activities from calf thymus. Biochem. Biophys. Res. Commun., 38, 165-171.
41. Lindell, T.J., Weinberg, F., Morris, P.W., Roeder, R.G. and Rutter, W.J. (1970) Specific inhibition of nuclear RNA polymerase II by alpha-amanitin. Science, 170, 447-449.
42. Broussau, S., Jabbour, N., Lachapelle, G., Durocher, Y., Tom, R., Transfiguracion, J., Gilbert, R. and Massie, B. (2008) Inducible packaging cells for large-scale production of lentiviral vectors in serum-free suspension culture. Mol. Ther., 16, 500-507.
43. Stoger, R., Kubicka, P., Liu, C.G., Kafri, T., Razin, A., Cedar, H. and Barlow, D.P. (1993) Maternal-specific methylation of the imprinted mouse Igf2r locus identifies the expressed locus as carrying the imprinting signal. Cell, 73, 61-71.
44. Wutz, A., Smrzka, O.W., Schweifer, N., Schellander, K., Wagner, E.F. and Barlow, D.P. (1997) Imprinted expression of the Igf2r gene depends on an intronic CpG island. Nature, 389, 745-749.
45. Hu, J.F., Balaguru, K.A., Ivaturi, R.D., Oruganti, H., Li, T., Nguyen, B.T., Vu, T.H. and Hoffman, A.R. (1999) Lack of reciprocal genomic imprinting of sense and antisense RNA of mouse insulin-like growth factor II receptor in the central nervous system. Biochem. Biophys. Res. Commun., 257, 604-608.
46. Hu, J.F., Pham, J., Dey, I., Li, T., Vu, T.H. and Hoffman, A.R. (2000) Allele-specific histone acetylation accompanies genomic imprinting of the insulin-like growth factor II receptor gene. Endocrinology, 141, 4428-4435.
47. Bartolomei, M.S. (2009) Genomic imprinting: employing and avoiding epigenetic processes. Genes Dev., 23, 2124-2133.
48. Skaar, D.A., Li, Y., Bernal, A.J., Hoyo, C., Murphy, S.K. and Jirtle, R.L. (2012) The human imprintome: regulatory mechanisms, methods of ascertainment, and roles in disease susceptibility. ILAR J., 53, 341-358.
49. Mercer, T.R. and Mattick, J.S. (2013) Structure and function of long noncoding RNAs in epigenetic regulation. Nat. Struct. Mol. Biol., 20, 300-307.
50. Nagano, T. and Fraser, P. (2011) No-nonsense functions for long noncoding RNAs. Cell, 145, 178-181.
51. Wang, J., Shen, L., Najafi, H., Kolberg, J., Matschinsky, F.M., Urdea, M. and German, M. (1997) Regulation of insulin preRNA splicing by glucose. Proc. Natl. Acad. Sci. U.S.A., 94, 4360-4365.
52. Mondal, T., Rasmussen, M., Pandey, G.K., Isaksson, A. and Kanduri, C. (2010) Characterization of the RNA content of chromatin. Genome Res., 20, 899-907.
53. Nguyen, V.T., Giannoni, F., Dubois, M.F., Seo, S.J., Vigneron, M., Kedinger, C. and Bensaude, O. (1996) In vivo degradation of RNA polymerase II largest subunit triggered by alpha-amanitin. Nucleic Acids Res., 24, 2924-2929.
54. Ferrai, C., Xie, S.Q., Luraghi, P., Munari, D., Ramirez, F., Branco, M.R., Pombo, A. and Crippa, M.P. (2010) Poised transcription factories prime silent uPA gene prior to activation. PLoS Biol., 8, e1000270.
55. Hu, J., Vu, T. and Hoffman, A. (1995) Differential biallelic activation of three insulin-like growth factor II promoters in the mouse central nervous system. Mol. Endocrinol., 9, 628-636.
56. Barlow, D.P. (1997) Competition-a common motif for the imprinting mechanism? EMBO J., 16, 6899-6905.
57. Latos, P.A., Pauler, F.M., Koerner, M.V., Senergin, H.B., Hudson, Q.J., Stocsits, R.R., Allhoff, W., Stricker, S.H., Klement, R.M., Warczok, K.E. et al. (2012) Airn transcriptional overlap, but not its IncRNA products, induces imprinted Igf2r silencing. Science, 338, 1469-1472.
58. Pauler, F.M., Koerner, M.V. and Barlow, D.P. (2007) Silencing by imprinted noncoding RNAs: is transcription the answer? Trends Genet., 23, 284-292.
59. Shearwin, K.E., Callen, B.P. and Egan, J.B. (2005) Transcriptional interference-a crash course. Trends Genet., 21, 339-345.
60. Wutz, A., Rasmussen, T.P. and Jaenisch, R. (2002) Chromosomal silencing and localization are mediated by different domains of Xist RNA. Nat. Genet., 30, 167-174.
61. Panning, B., Dausman, J. and Jaenisch, R. (1997) X chromosome inactivation is mediated by Xist RNA stabilization. Cell, 90, 907-916.
62. Chu, Y., Kalantari, R., Dodd, D.W. and Corey, D.R. (2012) Transcriptional silencing by hairpin RNAs complementary to a gene promoter. Nucleic Acid Ther., 22, 147-151.
63. Janowski, B.A., Huffman, K.E., Schwartz, J.C., Ram, R., Hardy, D., Shames, D.S., Minna, J.D. and Corey, D.R. (2005) Inhibiting gene expression at transcription start sites in chromosomal DNA with antigene RNAs. Nat. Chem. Biol., 1, 216-222.
64. Morris, K.V. (2011) The emerging role of RNA in the regulation of gene transcription in human cells. Semin. Cell Dev. Biol., 22, 351-358.
65. Splinter, E., de Wit, E., Nora, E.P., Klous, P., van de Werken, H.J., Zhu, Y., Kaaij, L.J., van Ijcken, W., Gribnau, J., Heard, E. et al. (2011) The inactive X chromosome adopts a unique three-dimensional conformation that is dependent on Xist RNA. Genes Dev., 25, 1371-1383.
66. Sleutels, F., Zwart, R. and Barlow, D.P. (2002) The non-coding Air RNA is required for silencing autosomal imprinted genes. Nature, 415, 810-813.
67. Tsai, M.C., Manor, O., Wan, Y., Mosammaparast, N., Wang, J.K., Lan, F., Shi, Y., Segal, E. and Chang, H.Y. (2010) Long noncoding RNA as modular scaffold of histone modification complexes. Science, 329, 689-693.
68. Tsai, C.L., Rowntree, R.K., Cohen, D.E. and Lee, J.T. (2008) Higher order chromatin structure at the X-inactivation center via looping DNA. Dev. Biol., 319, 416-425.
69. Qiu, X., Vu, T.H., Lu, Q., Ling, J.Q., Li, T., Hou, A., Wang, S.K., Chen, H.L., Hu, J.F. and Hoffman, A.R. (2008) A complex deoxyribonucleic Acid looping configuration associated with the silencing of the maternal igf2 allele. Mol. Endocrinol., 22, 1476-1488.
70. Murrell, A., Heeson, S. and Reik, W. (2004) Interaction between differentially methylated regions partitions the imprinted genes Igf2 and H19 into parent-specific chromatin loops. Nat. Genet., 36, 889-893.
71. Howard, T.K., Algar, E.M., Glatz, J.A., Reeve, A.E. and Smith, P.J. (1993) The insulin-like growth factor 1 receptor gene is normally biallelically expressed in human juvenile tissue and tumours. Hum. Mol. Genet., 2, 2089-2092.
72. Ogawa, O., McNoe, L.A., Eccles, M.R., Morison, I.M. and Reeve, A.E. (1993) Human insulin-like growth factor type I and type II receptors are not imprinted. Hum. Mol. Genet., 2, 2163-2165.
73. Barlow, D.P., Stoger, R., Hermann, B.G., Saito, K. and Schweifer, N. (1991) The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus. Nature, 349, 84-87.
74. Barlow, D.P. (1995) Gametic imprinting in mammals. Science, 270, 1610-1613.
75. Wutz, A. and Barlow, D.P. (1998) Imprinting of the mouse Igf2r gene depends on an intronic CpG island. Mol. Cell. Endocrinol., 140, 9-14.